Recent Blog Articles

Heart Health

Niacin + a statin does not add up to benefit

Updated: February 01, 2012

In 2011, federal health officials ended an important government-funded clinical trial designed to test whether taking niacin in addition to a cholesterol-lowering statin might do more to lower heart attack and stroke risk than just taking a statin alone. Interim data indicated that the niacin had no benefit and may have been associated with a small, unexplained increase in stroke risk.

Full results of the AIM-HIGH trial, as it was called, were published several months later in The New England Journal of Medicine. Experts continue to fight over the AIM-HIGH results in that ferocious way that experts often do. Some say the results are strong evidence for not adding niacin to statin therapy. Others are adamant that AIM-HIGH missed the mark because of the way it was designed and that it will take the results of a different trial, dubbed THRIVE, to determine if niacin-statin combinations have cardiovascular benefits.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».

Disclaimer:

As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.